Subjects administrating AngII-stimulating antihypertensives had significantly lower risk of developing dementia compared to AngII-inhibiting drugs, independently of systolic BP or the baseline history of stroke, diabetes or CV diseases. This evidence concerns the gene AGT and stroke disorder.